Latest news with #IIM
New Indian Express
21 hours ago
- Science
- New Indian Express
'Telangana ready for IIM, we are exploring possibilities': Indore institute director
A total of 20 officers received Bachelor of Technology degrees Lt D Subhash was awarded the DGEME Gold Medal and the GOC-in-C ARTRAC Trophy for being the best all-round student officer. Lt Abhinav Nair and Lt Adarsh Kumar Singh received the Commandant's Silver Medal for securing first position in the Mechanical and Electronics streams, respectively. The ceremony also featured a showcase of innovative technical projects developed by the officers, underlining the institution's focus on applied research and real-world problem-solving. Speaking on the sidelines, when asked whether Telangana is ready for an Indian Institute of Management, Prof Rai told TNIE, 'Telangana is definitely capable of having an IIM. It already hosts excellent institutions, and we at IIM Indore are exploring possibilities to initiate something here.' He also commented on Chief Minister A Revanth Reddy's vision of transforming Hyderabad into an AI city. 'Hyderabad has the right ecosystem, and, most importantly, the political will to become an AI city. With strong leadership and bureaucratic alignment, the city is ready though traffic management remains an area for improvement.'
News18
2 days ago
- Business
- News18
IIM Kashipur Clarifies Viral Placement Opt-Out Email, Assures Continued Student Support
Last Updated: The email sent by the Student Placement Committee was intended to accurately categorise students and better support those who are currently unplaced, IIM Kashipur said. A recent post on microblogging site X shared by Siddharth Gopi, Co-founder of claimed that IIM Kashipur has asked unplaced students to officially opt out of the placement process. Students are being asked to exclude themselves from the placement process so that the institute can claim 100 per cent placement, the post stated. In response, IIM Kashipur has clarified that the it is part of a regular process required for placement data audits and assured support to students who are still 'unplaced". Some students either seek job opportunities outside the placement process or decide not to participate in placements for various personal or professional reasons. Hence, the email sent by the Student Placement Committee was intended to accurately categorise students and better support those who are currently unplaced, the IIM said. The institute added that it will continue to be provide support to all unplaced students. IIM Kashipur said it publishes third-party audited placement reports in accordance with the Indian Placement Reporting Standards (IPRS) for the past two years as it helps maintain transparency, the institute said. As part of this auditing process, it is required to collect signed declarations from each student— based on the classification table provided — to ensure that students who have secured jobs off-campus or are pursuing further education are not incorrectly classified as 'unplaced", the institute further clarified. 'To ensure transparency, IIM Kashipur has been publishing third-party audited placement reports in accordance with the Indian Placement Reporting Standards (IPRS) for the past two years, and we will continue to do so. As part of the auditing process, we are required to maintain signed declarations from each student—based on the classification table provided—without which students who have secured jobs off-campus or are pursuing further education would be incorrectly classified as 'unplaced", the IIM said in a statement. 'This classification not only helps in maintaining accurate records but also ensures that we provide correct data to prospective recruiters. The intent behind the email sent by the Student Placement Committee was to appropriately categorise students and to better support those who are currently unplaced. The email also clearly states that support will continue to be extended to all unplaced students," it added. IIM Kashipur has invited over 180 companies this year, it said. The audited placement report will soon be released on the official IIM Kashipur website.
India.com
2 days ago
- Entertainment
- India.com
Panchayat Season 4: Chandan Roy teases a twist, says 'Small things are blown out of proportion'
With the release of Season 4 of the much-loved comedy-drama series ' Panchayat ' just days away, actor Chandan Roy, who plays Vikas Shukla, has offered fans a glimpse into what they can expect from the new season, which premieres on Prime Video on June 24. In a candid interview with ANI , actor Chandan Roy said the upcoming season is his personal favourite and offered a glimpse into the elements that will define the new storyline.' So, it's coming on the 24th. I think it will come till the night of the 23rd. So, just watch, and you'll know what's going to happen and what's not. But yes, I want to share one thing with all of you. Season 4… Personally, it's my favourite. More than Season 1, 2, and 3. I'm not saying this just because I want you to watch it. I'm genuinely saying it,' he said. The actor didn't hesitate to drop hints about what sets the upcoming season apart.' There's a twist. I mean, the nature of Panchayat, its essence, is that this time we're playing around a lot more. We're blowing small things out of proportion, and this is something that happens a lot, especially in North India. Under the peepal tree, near the betel leaf shop, by the tea stall. We're bringing all these elements much more into season 4. So, I hope you will really enjoy it,' he added. For fans of the show, this could mean a return to the quintessential charm of rural India, where the everyday drama unfolds under the shade of trees, at tea stalls, or during community gossip. Season 3 of 'Panchayat' concluded on a tense cliffhanger, and the stakes were raised considerably. The series had built up to a shocking confrontation between the villagers of Phulera and the goons of MLA Chandrakishore. The escalating tension between the two sides culminated in a violent face-off, leaving viewers eagerly awaiting cliffhanger featured an attack on the local leadership, with Pradhanji sustaining a gunshot wound to the shoulder, while Abhishek's preparations for the CAT examination were disrupted by the ensuing violence. The key questions that remained unanswered at the end of Season 3 included: 'Who shot Pradhanji? 'Was it the MLA or someone else? 'Will Abhishek clear his CAT exam and be admitted to IIM?' What will be the outcome of the Panchayat elections? 'Will peace return to Phulera, or will the violence escalate further?' These questions continue to dominate the minds of fans as they await the release of Season 4. Season 4 promises to pick up right from where season 3 left off, delving into the aftermath of the political violence and the unresolved questions surrounding the Panchayat elections. If the teaser trailer is anything to go by, Phulera appears to have turned into a political battleground, with campaign slogans, fiery rallies, and underhanded tactics. The contest for the Pradhan's seat intensifies between Manju Devi and Kranti Devi. The upcoming season will see the return of Jitendra Kumar as Sachiv Ji, alongside Neena Gupta, Raghubir Yadav, Faisal Malik, Chandan Roy, Sanvikaa, Durgesh Kumar, Sunita Rajwar, and Pankaj Jha–each contributing to the growing political tension in Phulera. Created by Deepak Kumar Mishra and Chandan Kumar, and directed by Mishra along with Akshat Vijaywargiya, the new season promises to bring back the show's signature blend of satire, warmth, and rustic charm.
Hindustan Times
3 days ago
- Business
- Hindustan Times
Advance your career with IIM Calcutta's Executive Programme in Human Resource Management. Apply now to lead
As businesses adapt to digital change, global talent pool and hybrid work, HR professionals must take on tactical roles. According to Gartner's 2024 HR Leaders Survey, 59% of organisations plan to boost investment in manager development. This highlights the crucial role of HR managers in shaping strong leadership, supporting transformation, and ensuring managers are prepared for the challenges of hybrid work, global teams, and rapid digital disruption. IIM Calcutta's Executive Programme in HR Management is uniquely positioned to help you build strong leadership, analytical and decisive skills to manage today's workforce challenges and support your organisation's growth and transformation. Taught by top IIM Calcutta faculty, this modern programme helps you understand HRM through a customer-focused lens—covering hiring, retention, skills mapping, job roles, and HR data insights. So, what makes this IIM HR course stand out? IIM Calcutta's EPHRM helps HR professionals become leaders, using data-driven methods, practical frameworks, and global insights to lead talent-focussed business transformation in today's fast-changing work environment. Explore the key details of the IIMC executive programme, designed to boost your HR expertise and advance your career. Live online video lectures: You can attend interactive sessions from anywhere, gaining real-time insights from experienced faculty without relocating or pausing your career. Assignments: You will apply your learning through practical tasks that reinforce concepts and build your confidence in real HR scenarios. Learning and networking with peers: You'll collaborate with professionals from diverse industries, expanding your perspective and building a valuable professional network. Executive education alumni status: You gain lifelong access to alumni privileges, networking events, and exclusive learning resources from a prestigious institution. Real-world case studies/examples: You learn from actual business challenges, enhancing your problem-solving skills and prudent HR decision-making abilities. 4-day campus immersion: You'll experience on-campus learning, interact face-to-face with faculty and peers, and engage in intensive, hands-on sessions. Learn from future-ready HR modules: You stay ahead with modules focused on emerging HR trends and technologies shaping the future workplace. Get an overview of this IIM Calcutta programme's curriculum designed to build future-ready HR of human resource management: You will explore core HR functions like recruitment, training, performance management, and employee engagement in today's workplace. Basics of organisational behaviour: Understand how people behave in organisations and learn how to manage motivation, communication, and team dynamics effectively. Contemporary talent management: Learn how to attract, develop, and retain talent using modern tools and techniques aligned with business needs. Strategic HRM (SHRM): Discover how to align HR strategies with business goals to improve performance and build a competitive workforce . General management: Build a broader business perspective with key concepts in finance, marketing, and operations for informed HR decisions. Contemporary HRM issues: Understand current HR issues, including diversity and inclusion, HR analytics, and new forms of work. Campus visit module: Participate in an on-campus learning experience with hands-on sessions, peer interaction, and faculty engagement. Offered by the prestigious IIM Calcutta, this programme gives your HR career a powerful edge. The curriculum is thoughtfully crafted to meet current industry demands. You gain real-world knowledge, expert insights, and valuable connections. Designed to build thinking, it prepares you to lead with confidence. Master key HR concepts from individual behaviour to organisational culture, while learning to tackle modern challenges through analytics, innovation, and strategy, people-focused practices that drive business success. Whether you're a student or a professional, this course sets you apart in the HR field. This programme helps mid-career professionals and line managers enhance people management skills. Senior practitioners also gain by learning to apply human-centric strategies for real-world HR challenges and meaningful use of human capital. Starts on: June 28, 2025 Duration: 1 Year Programme fee: ₹3,60,000 + GST Application fee: INR 2,000 + GST Eligibility: Working Professionals with 2+ years of work experience About Emeritus Emeritus offers customised and open programmes in India, Singapore, Dubai, and other global locations in collaboration with IIM Lucknow Executive Education, IIM Calcutta Executive Education, ISB Executive Education, Harvard Business School (HBS), MIT Sloan, Columbia Business School, Kellogg Executive Education, Berkeley Executive Education, and Wharton Executive Education, amongst other leading Institutions. Our world-class executive education programs, facilitated by eminent program experts, provide an immersive learning experience integrated with actionable insights and practical business applications and are delivered in a range of formats; in-class, online, as well as blended programs. The Emeritus Group has more than 1,750 employees globally and offices in Mumbai, New Delhi, Shanghai, Singapore, Palo Alto, Mexico City, New York, Boston, London, and Dubai. The company is backed by the Chan Zuckerberg Initiative, Leeds Illuminate, Prosus Ventures, GSV Ventures, Peak XV, Bertelsmann, CPPIB, Accel and SoftBank Vision Fund 2. For more information, please visit Disclaimer: This article is written on behalf of Emeritus, service provider for IIM Calcutta.
Business Upturn
3 days ago
- Health
- Business Upturn
Pulmonologists and Rheumatologists Struggle to Diagnose and Manage CTD-ILD, According to New Research from Spherix Global Insights
EXTON, PA, June 17, 2025 (GLOBE NEWSWIRE) — According to Spherix Global Insights' newly published Special Topix™: Interstitial Lung Disease in Rheumatology (US) report, both rheumatologists and pulmonologists report significant challenges in diagnosing and managing connective tissue disease-associated interstitial lung disease (CTD-ILD), with systemic sclerosis (SSc) and myositis (IIM) cited as the most difficult subtypes to treat. The research, based on responses from 138 US specialists (n=68 rheumatologists and 70 pulmonologists), highlights persistent unmet needs, diagnostic ambiguity, and a call for more robust and collaborative management strategies. The findings reflect that undiagnosed and misdiagnosed patients make up a substantial portion of the CTD-ILD population, with nearly one-third of rheumatologists and over half of pulmonologists naming differential diagnosis as a key challenge. Specialists underscore a lack of specific biomarkers, logistical biopsy issues, and overlapping symptoms as primary obstacles. 'The most definitive test (biopsy) is invasive. It is difficult to find the clinicians who are willing to do it in a timely manner, and to convince the patient it needs to be done.' – Rheumatologist 'Ensuring the correct diagnosis to avoid misdiagnosing the type of ILD or source of ILD. I usually employ the assistance of a rheumatologist.' – Pulmonologist 'Often it would be difficult to get patients biopsied for logistical reasons, and often the pathology report would not be precise enough.' – Pulmonologist Even once diagnosed, CTD-ILD patients face a treatment landscape with few options to slow or halt disease progression. When asked about the most difficult aspects of management, specialists consistently pointed to a lack of effective and targeted therapies, with SSc-ILD and myositis-ILD receiving the highest unmet need scores. For SSc-ILD specifically, not only is it associated with the most aggressive progression and worst long-term outcomes, but it also presents a uniquely complex therapeutic challenge. The clinical burden is especially pronounced in patients with diffuse cutaneous systemic sclerosis (dcSSc), where the use of corticosteroids is often limited due to the heightened risk of scleroderma renal crisis. This leaves physicians with a narrow band of anti-fibrotic and immunosuppressive options, many of which are perceived as only modestly effective in controlling ILD progression, let alone reversing it. Even therapies with regulatory approval for SSc-ILD, such as Boehringer Ingelheim's OFEV (nintedanib), garner only measured enthusiasm from treating physicians. While rheumatologists acknowledge nintedanib's potential to slow functional decline, they note it does little to address the underlying autoimmune pathology. Similarly, mycophenolate mofetil and rituximab remain staples of clinical practice, yet their real-world performance is viewed as inconsistent and difficult to monitor. Across the board, satisfaction ratings for currently utilized agents fall short of expectations, reinforcing a treatment landscape still dominated by trial-and-error approaches. This disconnect between disease complexity and treatment efficacy is fueling demand for dual-acting agents, therapies that can address both systemic autoimmunity and pulmonary fibrosis. Nowhere is this demand more visible than in systemic lupus erythematosus-associated ILD (SLE-ILD), where rheumatologists express growing interest in GSK's Benlysta (belimumab). Though not currently approved for ILD, belimumab's immunologic mechanism and expanded label for lupus nephritis have raised hopes that similar benefit may extend to pulmonary manifestations. Across interviews and survey feedback, physicians articulate a desire for treatments that reduce systemic activity while simultaneously preventing fibrotic progression—without the need for an antifibrotic add-on with limited synergy. Looking ahead, specialists are cautiously optimistic about the pipeline. While interest in agents with antifibrotic and immunomodulatory properties is rising, physicians emphasize that what's most needed is not just another drug, but a paradigm shift—a treatment model that reflects the multifaceted nature of CTD-ILD. As one physician summarized, the goal is to 'treat the patient, not just the lungs.' In addition to tracking physician sentiment and practice patterns, the study includes target product profile evaluations for several pipeline therapies: Benlysta (GSK), BMS-986278 (Bristol Myers Squibb), Nerandomilast (Boehringer Ingelheim), and Treprostinil (United Therapeutics). These profiles offer manufacturers timely insights into clinical expectations, adoption potential, and differentiation opportunities in an increasingly complex ILD treatment landscape. Special Topix™ is an independent service that includes access to a report or series of reports based on current events or topics of interest in specialty markets covered by Spherix. About Spherix Global Insights Spherix is a leading independent market intelligence and advisory firm that delivers commercial value to the global life sciences industry, across the brand lifecycle. The seasoned team of Spherix experts provides an unbiased and holistic view of the landscape within rapidly evolving specialty markets, including dermatology, gastroenterology, rheumatology, nephrology, neurology, ophthalmology, and hematology. Spherix clients stay ahead of the curve with the perspective of the extensive Spherix Physician Community. As a trusted advisor and industry thought leader, Spherix's unparalleled market insights and advisory services empower clients to make better decisions and unlock opportunities for growth. To learn more about Spherix Global Insights, visit or connect through LinkedIn. For more details on Spherix's primary market research reports and interactive dashboard offerings, visit or register here: NOTICE: All company, brand or product names in this press release are trademarks of their respective holders. The findings and opinions expressed within are based on Spherix Global Insight's analysis and do not imply a relationship with or endorsement of the companies or brands mentioned in this press release. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
